creature from the black lagoon slot
HYDERABAD, India -- Dr. Reddy's Laboratories Ltd.(NYSE: RDY) today announced its unaudited financial results for the quarter ended June 30, 2006. Key highlights -- Revenues at Rs 14. 0 billion as against Rs 5. 6 billion in Q1 FY06. YoY growth of 151% driven by combination of growth in core businesses, contributions from acquisitions & authorized generics opportunity.-- Revenues from international markets at Rs 11. 7 billion; Contribute 83% to total revenues -- Revenues from India increase by 15% to Rs 2. 4 billion.-- Revenues from authorized generics contribute 24% to revenues and acquisitions contribute 23% to total revenues.-- Revenues from core businesses (excluding the revenues from authorized generics and acquisitions), increase by 34% to Rs 7,462 million from Rs 5,587 million -- Gross profits increase to Rs 6. non gambling in nv slot machine game room minimum outside bets at online casinos slot back gaffed or crooked gambling
